ReAlta Life Sciences is an early stage biopharmaceutical company dedicated to addressing life-threatening medical needs through beneficial inhibition of the Complement System and Inflammatory Mechanisms. Founded in 2018, ReAlta Life Sciences is backed by investors that include Children’s Research Holdings and Marathon Pharmaceuticals and is headquartered in Norfolk.